Financials
Financial year 2025
API PHARMA from Liège, company number BE0805949739, closed financial year 2025 with a result of € 33,164 after tax. For that financial year API PHARMA recorded a gross margin of € 52,678 and equity of € 69,569. Compared with financial year 2024, the result moved from € 34,976 to € 33,164. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
€ 69,569
▲ 87% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 33,164
▼ 5% vs 2024
Profit after tax over the fiscal year.
€ 90,141
▲ 93% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 833 paid out
3 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 15,037
▼ 37% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 11,397
▼ 36% vs 2024
€ 6,750 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 493
▼ 72% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 27,605
▲ 57% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 3,020 | € 50,122 | € 52,678 | ▲ 5% |
| Profit after taxes | € 1,955 | € 34,976 | € 33,164 | ▼ 5% |
| Equity | € 3,122 | € 37,239 | € 69,569 | ▲ 87% |
| Total debts | € 20,224 | € 44,056 | € 46,890 | ▲ 6% |
| Cash | € 14,879 | € 46,660 | € 90,141 | ▲ 93% |
| Retained profit | € 1,122 | € 35,239 | € 67,569 | ▲ 92% |
| Dividend | € 833 | € 859 | € 833 | ▼ 3% |
| Bank debt | € 0 | € 17,891 | € 11,397 | ▼ 36% |
| Balance sheet total | € 23,346 | € 81,294 | € 116,460 | ▲ 43% |
Key figures of API PHARMA, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to API PHARMA?
What happened at API PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 33,164 (▼ 5% vs 2024). Source: NBB ↗
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
- Alice PIRENNE became a director. NBB
In short
From € 1,955 profit in 2023 to € 33,164 profit in 2025.
Paid € 20,396 in corporate taxes since 2023.
Best year ever: 2024, with € 34,976 profit.
Paid out € 2,525 in dividends to the owners in total.
A new publication or filing at API PHARMA? We notify you, reason included.
Follow API PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Alice PIRENNE
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Boulevard Frère-Orban 34 box 5b
4000 Liège
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0805.949.739
- VAT number
- BE 0805.949.739
- Registered office
- Boulevard Frère-Orban 34 bus 5b, 4000 Liège
- Names & denominations
- API PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 September 2023
- Peppol
- Active · Active since 23 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige vormen van onderwijs
Beroepsopleiding
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Adviesbureaus op het gebied van public relations en communicatie